Companies: 10,795·Total market cap: $144.5T

ImageneBio Inc

ImageneBio Inc

IMANASDAQHealthcare● Active

$5.52

$-0.11(-1.95%)

Market Cap$62260798

P/E Ratio—

52W High$18

52W Low$3.94

Avg Volume350K

Open$5.57

Beta0.72

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

ImageneBio Inc（IMA）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · IMA · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-4.64Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding4.9MShares outstanding history

Next EarningsJul 23, 2026Est.Earnings history

探索 ImageneBio Inc 数据

分析师预测$1 · Buy

股息不分红

营收$800000-77.14%

盈利EPS $-10.76-954.90%

财务快照

FY 2025Revenue$800000.00▼ 77.14% YoY

202320242025

FY 2025Net Income-$45.3M▼ 24.01% YoY

202320242025

FY 2025EPS$-10.76▼ 954.90% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$45.1MEPS: $-4.64View income statement →

分析师评级与目标价

Buy5 位分析师

Strong Buy

0

Buy

4

Hold

0

Sell

1

Strong Sell

0

12-Month Price Target

$1.33Low

$5.52Current

$1.33Avg Target下行风险 75.91%

$1.33High

合计: 5 · 买入占比: 80.0%

根据过去 3 个月内 5 位华尔街分析师，IMA 共识评级为 Buy，12 个月平均目标价 $1.33 （较现价 $5.52 下行风险 75.91%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$5.52-1.95%$62.3M #2

Artiva Biotherapeutics, Inc.

$6.80+4.63%$168.1M #3

Connect Biopharma Holdings Limited

$2.20+2.95%$138.5M #4

Context Therapeutics Inc.

$1.71-2.05%$157.1M #5

$1.71+0.29%$123.5M #6

Kalaris Therapeutics Inc

$4.17+0.65%$78.0M

股票表现

1D-0.35%

1W-1.05%

1M+6.43%

3M-4.90%

YTD-18.41%

1Y-68.08%

5Y-96.96%

关于 ImageneBio Inc

CEOKristin Yarema

IPO DateFeb 27, 1998

Employees10

CountryUS

Websiteinmagenebio.com

ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and in…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

ImageneBio Inc（IMA）是 Biotechnology 行业的 Healthcare 类公司，于 Feb 27, 1998 在 NASDAQ 上市。截至最近交易日，IMA 股价为 $5.52，市值约为 $62.3M。过去12个月累计回报 -68.08%，年初至今回报 -18.41%。

根据 5 位华尔街分析师，ImageneBio Inc 股票共识评级为Buy，12个月平均目标价为 $1.33。2025 财年 ImageneBio Inc 营收 $800000.00，净利润 -$45.3M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，ImageneBio Inc（IMA）股价为 $5.52，在 NASDAQ 上市，52周区间为 $3.94 – $18.00。

IMA 最新股价IMA quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议